undamentalytics Newsletter
Sign in

Natural Health Trends Corp (NHTC) stock

Add to watchlist

Add holding +

NASDAQ: NHTC Nasdaq Personal Care Products Next results ~February 3, 2027

C Fundamentals grade

Natural Health Trends Corp is a US-listed company in the personal care products industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$2.9

Revenue-to-maturity cash-flow model

Base case. Range ~$2.9–$3.3 across our lower- and higher-growth cases (0%–5% a year).

Price vs value

No Buy/Hold/Sell rating is issued: only 2 valuation models apply; a rating needs 3.

Natural Health Trends Corp valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds7 adding, 11 cuttingOf 3 active managers that changed their stake, 1 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Natural Health Trends files

Where Natural Health Trends stands after its latest 10-Q

Revenue for the twelve months to September 2026 was $34m, down 16.5% on a year earlier, a steeper fall than the 14.4% decline a quarter earlier. That puts it 16 of 17 for growth among the personal care products companies we cover. Free-cash-flow margin fell to -13.7% from -12.3% a year earlier. Operating margin narrowed to -5.9% from -3.9%. The diluted share count is down 15.7% on a year earlier, which lifts each remaining share. Against its peers on growth, profitability, cash generation and balance sheet, it grades C. It passes 2 of our 2 financial-health checks. Our revenue-to-maturity cash-flow model value is $3.20 a share.

Source: 10-Q filed October 28, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~February 3, 2027 (estimated)

Natural Health Trends Corp's trailing-twelve-month revenue fell 16.5% year on year, with a free-cash-flow margin of -13.7%. Where it stands out: stock pay as % of revenue of 0.1% ranks 1 of 18 personal care products companies we cover. Where it lags: free-cash-flow margin of -13.7% ranks 21 of 21 personal care products companies we cover.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 7.3% while net income fell 1107.6%: a 1115pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Shrinking share count. Diluted shares fell 15.7% in a year, so each share owns more of the business.
  • Net cash. Cash exceeds long-term debt by $0.0bn.

Things to watch

  • Revenue shrinking. Revenue fell 16.5% over the last 12 months.
  • Loss-making. Operating margin is -5.9%: costs exceed revenue.
  • Burning cash. Free cash flow was -13.7% of revenue over the last 12 months.
  • Volatile shares. Over the past year the shares showed annualised volatility of 81% and a beta of 1.0 against the S&P 500.
  • Growth easing. The growth rate is 2.1 points lower than a quarter earlier.
  • Below peers: change in growth rate. Change in growth rate of -2.1pp ranks 17 of 21 personal care products companies we cover (median +0.7pp).

Latest results: FY2026 Q3

Filed October 28, 2026
Revenue
$8m, down 20.2% on a year earlier
Share reaction
-10.5% in the first session after the results on October 28, 2026, against 0.0% for the S&P 500
Next report
October 28, 2026

Natural Health Trends' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+4.0%
  • 1 week-12.4%
  • 1 month-22.0%
  • This year-73.2%
  • 1 year-80.0%
  • 5 years-80.2%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$34.1M
Operating margin
-5.9%
Net margin
-4.2%
EPS (TTM, diluted)
$-0.15

Growth

Revenue growth
−16.5%
Change in growth rate
−2.1 pts
Share count change
−15.7%

Cash

Free cash flow (TTM)
-$4.7M
FCF margin
-13.7%
Stock pay % of revenue
0.1%

Earnings

Last results
October 28, 2026
Next results (est.)
February 3, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Natural Health Trends Corp valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: only 2 valuation models apply; a rating needs 3.

Valuation models

We value Natural Health Trends Corp as an operating company, with every model that fits that kind of business. Cost of equity 7.9%: the 10-year Treasury yield (4.9%) plus a beta of 0.65 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. ~$2.9 ~$2.9–$3.3 Primary model, counts double
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: no positive earnings in the latest twelve months
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$0.2 ~$0.1–$0.5 Left out: far from the other models (more than 3x away from their median)
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. ~$2.0 ~$1.5–$9.6 Included, half weight
Combined value Weighted average of the models that apply: the primary model (revenue-to-maturity model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$2.7 ~$2.0–$2.9 2 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Natural Health Trends Corp with Personal Care Products in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$10.56$8.01$5.22$7.25$2.27$2.42$3.65$2.11$4.14$3.66$2.91$0.78
Market value$131m$91m$59m$82m$25m$28m$42m$24m$47m$42m$33m$8m
+ Net debt (− = net cash)−$105m−$126m−$135m−$133m−$96m−$92m−$84m−$70m−$56m−$14m−$7m−$6m
Enterprise value$26m−$35m−$76m−$51m−$71m−$65m−$42m−$46m−$9m$29m$27m$2m
Multiples
Price / sales 0.5x0.3x0.3x0.4x0.3x0.4x0.7x0.5x1.1x1.0x0.8x0.2x
Price / earnings 2.8x1.7x2.5x2.6x—32.9x38.4x77.0x83.5x73.6x——
Price / free cash flow 1.6x1.7x2.2x2.8x—16.5x52.6x—————
EV / EBITDA 0.5xn/mn/mn/m—n/mn/m—————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

67 /100

Moderate moat

How hard Natural Health Trends's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 20 / 20

    Cash operating profit has been a median 151.0% of total assets over 5 years.

  • Pricing power 19 / 20

    Gross margin has been a median 74.3%, moving by 2.7 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median -1.1%; its worst year was -6.1%.

  • Cash conversion 3 / 20

    Free cash flow was positive in 3 of 10 years, at a median -7.8% of revenue.

  • Discipline 20 / 20

    The diluted share count fell 16.8% over five years; stock-based pay has been a median 0.1% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (72 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

No analyst estimates are published for Natural Health Trends Corp: too few analysts cover it.

Positioning

Short interest
0.6%
of tradable shares
Days to cover
0.44
at average volume
Short interest, 1 month
+30%
to October 15, 2026
Held by institutions
12%
of shares
Held by insiders
13.0%
of shares
Employees
118
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −80.0%

$3.90 on October 31, 2025 to $0.78

ThenNowEffect
Revenue (last 12 months) $42m $36m −14.4%
P/S multiple 1.1x 0.2x −78.8%
Share count 11m 10m +10.2%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years −79.6%

$3.82 on November 3, 2023 to $0.78

ThenNowEffect
Revenue (last 12 months) $47m $36m −22.7%
P/S multiple 0.9x 0.2x −76.0%
Share count 11m 10m +10.0%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
NHTC+50%−42%+96%−12%−21%−73%
Industry peers (median)+31%−32%+3%−8%−34%+1%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
NHTC58%58%58%67%58%27%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
NHTC−19%−53%−32%−42%−48%−80%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 96% from November 16, 2015 to October 30, 2026. Getting back needed a 2156% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$0.75 – $3.93
From 52-week high
−80.2%
vs 50-day average
−34.5%
vs 200-day average
−65.3%
Volatility (1 year)
81%
Beta vs S&P 500
0.99

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
7 up, 5 down
typical move ±6.4%
After a week
5 up, 6 down
typical move ±6.1%
After a month
4 up, 7 down
typical move ±7.7%
Results releasedNext dayS&P 500 next day5 days21 days
October 28, 2026 −10.5% 0.0% — —
July 29, 2026 −7.7% +0.1% −11.5% −6.0%
April 29, 2026 +4.7% +1.0% +4.0% −4.7%
February 4, 2026 −1.3% −1.7% −2.7% −12.6%
November 5, 2025 −42.5% −0.7% −17.6% −33.3%
July 30, 2025 +0.4% −0.5% +4.7% −2.3%
April 30, 2025 +0.6% +0.7% −0.2% +1.5%
February 5, 2025 −1.1% +0.8% −2.8% +3.0%
October 30, 2024 +1.7% −2.3% +4.1% −4.8%
July 31, 2024 +0.6% +0.2% −6.5% −4.4%
May 1, 2024 +3.4% +0.6% +4.8% +5.7%
February 7, 2024 +2.8% +0.9% +8.3% +6.9%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Natural Health Trends Corp in five measures

Fundamentals grade C
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Natural Health Trends Corp
$30M $35M $40M $45M FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $43.9M Revenue (TTM), FY24 Q1: $43M Revenue (TTM), FY24 Q2: $43M Revenue (TTM), FY24 Q3: $43.1M Revenue (TTM), FY24 Q4: $43M Revenue (TTM), FY25 Q1: $42.7M Revenue (TTM), FY25 Q2: $42.1M Revenue (TTM), FY25 Q3: $40.9M Revenue (TTM), FY25 Q4: $39.8M Revenue (TTM), FY26 Q1: $38.2M Revenue (TTM), FY26 Q2: $36M Revenue (TTM), FY26 Q3: $34.1M $34.1M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $43.9M
FY24 Q1 $43M
FY24 Q2 $43M
FY24 Q3 $43.1M
FY24 Q4 $43M
FY25 Q1 $42.7M
FY25 Q2 $42.1M
FY25 Q3 $40.9M
FY25 Q4 $39.8M
FY26 Q1 $38.2M
FY26 Q2 $36M
FY26 Q3 $34.1M
Revenue growth, TTM YoY Natural Health Trends Corp
-20% -15% -10% -5% 0% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: -10.6% Revenue growth, TTM YoY, FY24 Q1: -13.0% Revenue growth, TTM YoY, FY24 Q2: -7.8% Revenue growth, TTM YoY, FY24 Q3: -5.4% Revenue growth, TTM YoY, FY24 Q4: -2.2% Revenue growth, TTM YoY, FY25 Q1: -0.6% Revenue growth, TTM YoY, FY25 Q2: -2.1% Revenue growth, TTM YoY, FY25 Q3: -5.1% Revenue growth, TTM YoY, FY25 Q4: -7.4% Revenue growth, TTM YoY, FY26 Q1: -10.5% Revenue growth, TTM YoY, FY26 Q2: -14.4% Revenue growth, TTM YoY, FY26 Q3: -16.5% -16.5%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 -10.6%
FY24 Q1 -13.0%
FY24 Q2 -7.8%
FY24 Q3 -5.4%
FY24 Q4 -2.2%
FY25 Q1 -0.6%
FY25 Q2 -2.1%
FY25 Q3 -5.1%
FY25 Q4 -7.4%
FY26 Q1 -10.5%
FY26 Q2 -14.4%
FY26 Q3 -16.5%
Operating margin (TTM) Natural Health Trends Corp
-8% -6% -4% -2% 0% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: -3.8% Operating margin (TTM), FY24 Q1: -3.8% Operating margin (TTM), FY24 Q2: -2.6% Operating margin (TTM), FY24 Q3: -2.6% Operating margin (TTM), FY24 Q4: -3.0% Operating margin (TTM), FY25 Q1: -3.0% Operating margin (TTM), FY25 Q2: -3.3% Operating margin (TTM), FY25 Q3: -3.9% Operating margin (TTM), FY25 Q4: -4.5% Operating margin (TTM), FY26 Q1: -5.1% Operating margin (TTM), FY26 Q2: -6.2% Operating margin (TTM), FY26 Q3: -5.9% -5.9%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 -3.8%
FY24 Q1 -3.8%
FY24 Q2 -2.6%
FY24 Q3 -2.6%
FY24 Q4 -3.0%
FY25 Q1 -3.0%
FY25 Q2 -3.3%
FY25 Q3 -3.9%
FY25 Q4 -4.5%
FY26 Q1 -5.1%
FY26 Q2 -6.2%
FY26 Q3 -5.9%
FCF margin (TTM) Natural Health Trends Corp
-20% -15% -10% -5% 0% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: -9.8% FCF margin (TTM), FY24 Q1: -7.2% FCF margin (TTM), FY24 Q2: -9.4% FCF margin (TTM), FY24 Q3: -8.3% FCF margin (TTM), FY24 Q4: -8.0% FCF margin (TTM), FY25 Q1: -8.2% FCF margin (TTM), FY25 Q2: -13.2% FCF margin (TTM), FY25 Q3: -12.3% FCF margin (TTM), FY25 Q4: -15.2% FCF margin (TTM), FY26 Q1: -19.5% FCF margin (TTM), FY26 Q2: -9.7% FCF margin (TTM), FY26 Q3: -13.7% -13.7%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 -9.8%
FY24 Q1 -7.2%
FY24 Q2 -9.4%
FY24 Q3 -8.3%
FY24 Q4 -8.0%
FY25 Q1 -8.2%
FY25 Q2 -13.2%
FY25 Q3 -12.3%
FY25 Q4 -15.2%
FY26 Q1 -19.5%
FY26 Q2 -9.7%
FY26 Q3 -13.7%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 24 31 38 53 125 265 288 198 192 78 62 60 49 44 43 40 34
Gross profit 17 23 28 40 98 211 233 159 153 58 45 45 36 33 32 29 25
EBITDA −2 2 3 4 21 48 65 44 34 −7 1 2 −0 −2 −1 −2 −2
Operating income −3 2 3 4 21 48 64 43 34 −7 1 2 −0 −2 −1 −2 −2
Net income −2 2 3 4 20 47 55 24 31 −6 1 1 0 1 1 −1 −1
Diluted EPS −$0.23 $0.21 $0.23 $0.36 $1.61 $3.82 $4.83 $2.09 $2.74 −$0.52 $0.07 $0.09 $0.03 $0.05 $0.05 −$0.08 −$0.15
Growth (year on year)
Revenue — +32.2% +20.4% +40.0% +137.2% +112.6% +8.6% −31.3% −2.9% −59.6% −20.0% −3.3% −18.1% −10.6% −2.2% −7.4% −16.5%
EBITDA — — +29.3% +59.4% +387.9% +130.1% +34.0% −32.4% −21.7% −119.4% — — −103.5% — — — —
Operating income — — +48.3% +59.7% +393.0% +130.0% +34.0% −32.9% −21.7% −120.8% — — −117.2% — — — —
Net income — — +14.1% +55.5% +398.2% +131.9% +16.6% −57.2% +31.6% −118.1% — — — — — — —
Diluted EPS — — +9.5% +56.5% +347.2% +137.3% +26.4% −56.7% +31.1% −119.0% — — — — — — —
Margins
Gross margin 70.4% 73.8% 74.2% 76.1% 78.3% 79.6% 80.9% 80.4% 79.5% 74.1% 72.6% 75.0% 74.2% 74.6% 74.0% 73.5% 74.3%
EBITDA margin −7.9% 6.7% 7.2% 8.2% 16.8% 18.2% 22.4% 22.1% 17.8% −8.6% 1.7% 3.1% −0.1% −3.4% −2.7% −4.3% −5.7%
Operating margin −13.1% 5.7% 7.1% 8.0% 16.7% 18.1% 22.3% 21.8% 17.6% −9.0% 1.1% 2.6% −0.5% −3.8% −3.0% −4.5% −5.9%
Net margin −10.4% 7.4% 7.0% 7.8% 16.3% 17.8% 19.1% 11.9% 16.2% −7.2% 1.4% 1.8% 0.6% 1.3% 1.3% −2.2% −4.2%
Free-cash-flow margin −1.2% 4.7% 5.6% 19.9% 24.3% 30.4% 18.2% 13.3% 15.4% −24.3% 2.7% 1.3% −10.2% −9.8% −8.0% −15.2% −13.7%
Cash flow
Cash from operations −0 1 2 11 31 81 53 27 30 −19 2 1 −5 −4 −3 −6 −4
Capital spending 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0
Free cash flow −0 1 2 10 30 81 52 26 29 −19 2 1 −5 −4 −3 −6 −5
Stock-based pay 0 0 0 0 0 0 0 0 0 — — — 0 0 0 0 0
Free cash flow after stock pay −0 1 2 10 30 81 52 26 29 — — — −5 −4 −4 −6 −5
Balance sheet
Cash 1 2 4 15 45 105 126 135 133 96 92 84 70 56 14 7 6
Total debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net debt (negative = net cash) −1 −2 −4 −15 −45 −105 −126 −135 −133 −96 −92 −84 −70 −56 −14 −7 −6
Diluted shares 11m 11m 11m 11m 13m 12m 11m 11m 11m 11m 11m 11m 11m 11m 11m 11m 10m
Returned to shareholders
Dividends — — — — 0 2 7 17 32 7 9 9 9 9 9 9 4
Buybacks — — 0 0 5 16 24 0 0 10 0 — — — — — —
Total returned — — 0 0 5 18 31 17 32 17 9 9 9 9 9 9 4

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 2 checks passed · September 30, 2026
What it owns · $27m
Short-term assets $22mLonger-term assets $5m
What it owes, and who funded it · $27m
Short-term liabilities $10mLonger-term liabilities $2mShareholders' equity $15m
  • Short-term assets cover short-term liabilities $22m of assets due within a year against $10m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $22m short-term assets against $2m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Natural Health Trends Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Dividends (TTM)
$4M
Diluted share count
−15.7%
year over year
Total shareholder yield
60.0%
dividends 60.0% + buybacks 0.0% of market value
Sales & admin spending
40.3%
of revenue

Competitors: side by side with peers

Closest by revenue in personal care products
Last 12 months unless stated NHTC FTLF AXIL YCBD UG MTEX Median
Revenue, last 12 months $34m $36m $30m $21m $11m $107m $913m
Revenue growth, last 12 months −16.5% −43.3% 10.3% 10.0% 3.2% −5.0% 3.5%
Revenue growth, 3-year average −9.1% −3.0% −5.7% −7.3% 2.5% −7.7% −0.1%
Revenue growth, latest quarter −20.2% 64.6% −11.2% 20.6% 9.5% 3.8% 2.7%
Gross margin 74.3% 34.8% 72.4% 57.7% 46.9% 76.1% 69.2%
Operating margin −5.9% 10.9% 10.0% −13.9% 20.8% 2.5% 6.7%
Operating margin, 3-year average −4.1% 16.0% 6.9% −37.2% 25.5% 0.4% 5.5%
Net margin −4.2% 5.4% 9.3% −13.8% 22.0% −6.9% 3.4%
Cash from operations / revenue −12.3% 28.1% 14.9% −10.6% 30.9% 2.3% 9.9%
Free-cash-flow margin −13.7% 28.0% 14.5% −11.5% 30.3% 1.5% 9.6%
Free-cash-flow margin, 3-year average −11.4% 17.7% 7.1% −7.8% 26.4% −1.0% 6.0%
Stock pay / revenue 0.1% 0.1% 4.3% 4.2% — 0.4% 1.0%
Change in share count −15.7% 0.5% −5.5% — 0.0% 1.2% −0.0%

Median of all 21 companies we cover in personal care products. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

21 personal care products companies
Measure Company Peer median Rank
Revenue growth Growth -16.5% 3.5% 19 of 21
Change in growth rate Growth -2.1pp +0.7pp 17 of 21
Gross margin Profitability 74.3% 69.2% 7 of 21
Operating margin Profitability -5.9% 6.7% 20 of 21
Net margin Profitability -4.2% 3.4% 17 of 21
Free-cash-flow margin Cash generation -13.7% 9.6% 21 of 21
Stock pay as % of revenue Cash generation 0.1% 1.0% 1 of 18
Change in share count Balance sheet -15.7% -0.0% 1 of 19

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Primary Reporting $38.4M 96.5% ▼ 6.1%
China $946,000 2.4% ▼ 40.1%
Russia and Kazakhstan $444,000 1.1% ▼ 9.4%
Products and services
Line of business Revenue Share YoY
Products $39M 97.3% ▼ 6.5%
Administrative Fees Freight and Other $1.1M 2.7% ▼ 30.1%
Geography
Region Revenue Share YoY
Hong Kong $32.7M 82.1% ▼ 6.9%
Taiwan $1.5M 3.9% ▼ 3.1%
Peru and Colombia $1.2M 3.0% ▲ 9.4%
United States $1.2M 2.9% ▲ 10.4%
China $946,000 2.4% ▼ 40.1%
Europe $530,000 1.3% ▼ 16.5%
Other Foreign Countries $477,000 1.2% ▼ 19.0%
Canada $475,000 1.2% ▼ 11.2%
Russia and Kazakhstan $444,000 1.1% ▼ 9.4%
Japan $333,000 0.8% ▲ 14.0%

From Natural Health Trends Corp's 10-K filed February 20, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$1.8M
Institutions reporting
22
Shares held vs prior quarter
▼ 3.7%
Positions opened / closed
2 / 3

Top buyers and sellers, Q2 2026: 7 institutions bought and 11 sold ; the biggest buyer was Jane Street Group, LLC (+35K shares) and the biggest seller Blackrock, Inc (−21K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Renaissance Technologies LLC $963,016 544K 52.3% ▼ 2.0%
Blackrock, Inc. $169,191 96K 9.2% ▼ 17.7%
Geode Capital Management, LLC $155,816 88K 8.5% ▼ 17.0%
Vanguard Capital Management LLC $135,589 77K 7.4% 0.0%
Citadel Advisors LLC $67,062 38K 3.6% ▲ 13.4%
Vanguard Fiduciary Trust Co $61,782 35K 3.4% 0.0%
Jane Street Group, LLC $61,144 35K 3.3% New
State Street Corp $47,811 27K 2.6% 0.0%
Dimensional Fund Advisors LP $40,842 23K 2.2% ▼ 15.5%
Bridgeway Capital Management, LLC $40,002 23K 2.2% 0.0%
Xtx Topco Ltd $22,511 13K 1.2% ▲ 21.2%
Northern Trust Corp $22,249 13K 1.2% ▼ 19.1%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Natural Health Trends Corp's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around February 3, 2027 estimated from the company's past filing pattern, not announced

  • October 28, 2026
  • July 29, 2026
  • April 29, 2026
  • February 4, 2026
  • November 5, 2025
  • July 30, 2025

Recent SEC filings

Data status

When each part of this page on Natural Health Trends Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Natural Health Trends Corp in brief

What does Natural Health Trends Corp do?
Natural Health Trends Corp is a US-listed company in the personal care products industry. Its financial year ends in December.
What is Natural Health Trends Corp's stock ticker?
Natural Health Trends Corp trades under the ticker NHTC on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Natural Health Trends Corp's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Natural Health Trends Corp reported revenue of $34.1M, 16.5% lower than a year earlier, according to its SEC filings.
What is Natural Health Trends Corp's free cash flow?
Natural Health Trends Corp's free-cash-flow margin is -13.7% of revenue over the trailing twelve months, ranking 21 of the 21 personal care products companies we cover.
Who are Natural Health Trends Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Renaissance Technologies LLC, Blackrock, Inc. and Geode Capital Management, LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Natural Health Trends Corp's market cap?
On November 2, 2026, Natural Health Trends Corp's market capitalisation was about $7.6M and net debt of -$5.8M. Market figures come from third-party market data and may be delayed.
Does Natural Health Trends Corp pay a dividend?
Yes: Natural Health Trends Corp paid $4M in dividends over the trailing twelve months, a dividend yield of 60.04%.
Who are Natural Health Trends Corp's competitors?
In our Personal Care Products peer group, the companies closest to Natural Health Trends Corp are Fitlife Brands, Inc., Axil Brands, Inc., Cbdmd, Inc., United Guardian Inc and Mannatech Inc. The side-by-side comparison below sets their revenue, margins and growth against Natural Health Trends Corp's.
When is Natural Health Trends Corp's next earnings date?
Around February 3, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Natural Health Trends Corp announces its own schedule.